CXCL12 and prostate cancer: Prostate cancer cells can also release PKM2-carrying EVs to educate the bone marrow environment into a metastatic niche by transferring PKM2 to bone marrow stromal cells with subsequent upregulation of CXCL12 cytokine (39).